Warren Eric: insider trades.
Warren Eric reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($602K), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Warren Eric
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | Officer · Chief Commercial Officer | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-21 | Mineralys Therapeutics, Inc. | S | 7,438 | $28.12 | 38,400 | Form 4 |
| 2026-09-21 | Mineralys Therapeutics, Inc. | M | 7,438 | $13.24 | 45,838 | Form 4 |
| 2026-08-21 | Mineralys Therapeutics, Inc. | M | 7,437 | $13.24 | 45,837 | Form 4 |
| 2026-08-21 | Mineralys Therapeutics, Inc. | S | 7,437 | $25.98 | 38,400 | Form 4 |
| 2026-07-21 | Mineralys Therapeutics, Inc. | S | 7,438 | $26.87 | 38,400 | Form 4 |
| 2026-07-21 | Mineralys Therapeutics, Inc. | M | 7,438 | $13.24 | 45,838 | Form 4 |
Questions
What stock did Warren Eric buy or sell?
Warren Eric reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($602K), across 1 company.
Is Warren Eric the same person as other filers with this name?
This page covers SEC CIK 1916048 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/warren-eric-1916048.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.